These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17203528)

  • 1. Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review.
    Chavez-Tapia NC; Barrientos-Gutierrez T; Tellez-Avila FI; Sanchez-Avila F; Montano-Reyes MA; Uribe M
    World J Gastroenterol; 2006 Dec; 12(48):7826-31. PubMed ID: 17203528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
    Shyangdan D; Clar C; Ghouri N; Henderson R; Gurung T; Preiss D; Sattar N; Fraser A; Waugh N
    Health Technol Assess; 2011 Nov; 15(38):1-110. PubMed ID: 22059955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic trials in nonalcoholic steatohepatitis: insulin sensitizers and related methodological issues.
    Ratziu V; Caldwell S; Neuschwander-Tetri BA
    Hepatology; 2010 Dec; 52(6):2206-15. PubMed ID: 21105109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status.
    Stein LL; Dong MH; Loomba R
    Adv Ther; 2009 Oct; 26(10):893-907. PubMed ID: 19921118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial.
    Sofer E; Boaz M; Matas Z; Mashavi M; Shargorodsky M
    Metabolism; 2011 Sep; 60(9):1278-84. PubMed ID: 21411114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
    Angelico F; Burattin M; Alessandri C; Del Ben M; Lirussi F
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005166. PubMed ID: 17253544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review.
    Socha P; Horvath A; Vajro P; Dziechciarz P; Dhawan A; Szajewska H
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):587-96. PubMed ID: 19412008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic effects of insulin-sensitizing drugs on nonalcoholic fatty liver disease: experiment with rats].
    Zhang DM; Zhang GY; Wang T; Zhong HJ; Chen WK
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1279-83. PubMed ID: 16796890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of medications for the management of patients with NAFLD.
    Mazzella N; Ricciardi LM; Mazzotti A; Marchesini G
    Clin Liver Dis; 2014 Feb; 18(1):73-89. PubMed ID: 24274866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis.
    Rakoski MO; Singal AG; Rogers MA; Conjeevaram H
    Aliment Pharmacol Ther; 2010 Nov; 32(10):1211-21. PubMed ID: 20955440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of metformin in the management of NAFLD.
    Mazza A; Fruci B; Garinis GA; Giuliano S; Malaguarnera R; Belfiore A
    Exp Diabetes Res; 2012; 2012():716404. PubMed ID: 22194737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
    Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.
    Cosma M; Swiglo BA; Flynn DN; Kurtz DM; Labella ML; Mullan RJ; Elamin MB; Erwin PJ; Montori VM
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1135-42. PubMed ID: 18252787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease.
    Omer Z; Cetinkalp S; Akyildiz M; Yilmaz F; Batur Y; Yilmaz C; Akarca U
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):18-23. PubMed ID: 19667999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin sensitizers in nonalcoholic steatohepatitis.
    Harrison SA; Schenker S; Cusi K
    Hepatology; 2011 Apr; 53(4):1404-5; author reply 1405. PubMed ID: 21480350
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of insulin sensitizers in NASH.
    Khashab M; Chalasani N
    Endocrinol Metab Clin North Am; 2007 Dec; 36(4):1067-87; xi. PubMed ID: 17983937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
    Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
    Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis.
    Mahady SE; Webster AC; Walker S; Sanyal A; George J
    J Hepatol; 2011 Dec; 55(6):1383-90. PubMed ID: 21703200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial.
    Haukeland JW; Konopski Z; Eggesbø HB; von Volkmann HL; Raschpichler G; Bjøro K; Haaland T; Løberg EM; Birkeland K
    Scand J Gastroenterol; 2009; 44(7):853-60. PubMed ID: 19811343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of nonalcoholic steatohepatitis: antioxidants or insulin sensitizers?
    Adams LA; Angulo P
    Clin Gastroenterol Hepatol; 2004 Dec; 2(12):1059-60. PubMed ID: 15625648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.